ARGAN CEO Files Intent to Sell $6.57M in Common Stock Amidst Ongoing Insider Selling Trend
AGX has more than doubled off its 52-week low of $193.82 on light trading volume (0.1× avg).
Summary
ARGAN INC's President and CEO, David H. Watson, filed a Form 144 to sell $6.57 million worth of common stock, adding to a recent trend of significant insider selling despite the company's strong financial performance.
Key Events · Ownership and Investor Activity · AGX
-
CEO Files Intent to Sell Shares
David H. Watson, President and CEO, also a Director of ARGAN INC, filed a Form 144 indicating his intent to sell 9,993 shares of common stock.
-
Significant Dollar Value
The proposed sale is valued at approximately $6.57 million, representing a notable transaction by a top executive.
-
Continuation of Insider Selling Trend
This filing adds to a pattern of insider distribution, with over $38 million in net insider sales reported across 6 active insiders in the last 90 days.
Analysis · AGX · Real Estate & Construction
This Form 144 indicates the CEO's intent to sell a substantial amount of company stock, valued at $6.57 million. While the company has recently reported strong financial performance and increased its share repurchase program, this filing by the CEO contributes to an ongoing trend of significant insider selling. Such a sale by a top executive can be interpreted as a lack of conviction, potentially offsetting positive company news and raising questions about future growth prospects.
How filings like this one have moved
In the 30 days to Nov 8, 2026, 36.3% of the 2976 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, AGX was trading at $669.97 on NYSE in the Real Estate & Construction sector, with a market capitalization of approximately $9.4B. The 52-week trading range was $193.82 to $779.00. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.